Plus Therapeutics | 8-K: Current report
Mar 15 05:07
Plus Therapeutics | 8-K: Current report
Mar 13 20:03
Plus Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mar 9 05:32
Plus Therapeutics | 8-K: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Mar 6 05:13
Plus Therapeutics | 10-K: Annual report
Mar 6 05:03
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard
Feb 27 07:32
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaFrance Norman D.
Feb 27 07:32
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H
Feb 27 07:27
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre
Feb 27 07:27
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Feb 27 07:27
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An
Feb 27 07:27
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J
Feb 27 07:27
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg
Feb 27 07:26
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer HEDRICK MARC H
Dec 16, 2023 06:09
Plus Therapeutics | 424B3: Prospectus
Nov 23, 2023 05:22
Plus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Nov 23, 2023 05:08
Plus Therapeutics | EFFECT: Others
Nov 21, 2023 13:15
Plus Therapeutics | 8-K: Current report
Nov 20, 2023 20:01
Plus Therapeutics | CORRESP: CORRESP
Nov 18, 2023 02:49
Plus Therapeutics | UPLOAD: Others
Nov 18, 2023 00:36
No Data
No Data